Winton Group’s Apyx Medical APYX Stock Holding History

Winton Group’s Portfolio APYX Stock Details APYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-10,831	Closed	-$92K	–	1396
2019 Q4	$92K	Buy	+10,831	New	+$78.2K	﹤0.01%	1492
2019 Q3	–	Sell	-11,812	Closed	-$79K	–	1518
2019 Q2	$79K	Buy	+11,812	New	+$64.2K	﹤0.01%	1091

Other funds holding APYX

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

ACM

Archon Capital Management Seattle, Washington $246M AUM 130.69% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PVI

Pura Vida Investments New York $37M AUM 63.54% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

HKAM

Horizon Kinetics Asset Management New York $8.82B AUM 23.05% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

TFCM

Taylor Frigon Capital Management Scottsdale, Arizona $214M AUM 47.29% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Winton Group's APYX Position: Q1 2020 in Review

Winton Group sold out of Apyx Medical (APYX) in Q1 2020, closing a stake of 10,831 shares — an estimated $92K sold.

Winton Group first reported a position in APYX in Q2 2019 and held it in 2 quarters. The position peaked at $92K in Q4 2019. 67 funds tracked by Wall St. Rank hold APYX as of Q1 2020.

Winton Group reported no remaining Apyx Medical position as of Q1 2020 after selling out during the quarter.
Winton Group sold 10,831 Apyx Medical shares in Q1 2020, an estimated $92K.
Winton Group first reported a position in Apyx Medical in Q2 2019 and held it in 2 quarters.
Winton Group's Apyx Medical position peaked at $92K in Q4 2019.
67 funds tracked by Wall St. Rank held Apyx Medical as of Q1 2020.

Based on Winton Group's 13F filing for Q1 2020, filed 11 May 2020.